Invesaro

Stocks CSPI Financial statements

Financial statements

CSP INC /MA/ financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CSP INC /MA/ files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue10388.572.979.161.849.254.464.655.258.7
Cost of revenue78.367.154.56144.633.135.542.736.440.2
Gross profit2521.418.41817.216.118.821.918.918.5
Research and development2.982.363.282.82.82.893.083.142.963.25
Selling, general and administrative18.315.716.716.115.814.615.816.917.818.4
Operating expenses21.2182018.918.617.518.920.120.721.6
Operating income3.83.4-1.6-0.83-1.42-1.36-0.041.87-1.87-3.11
Interest expense0.240.36
Interest income0.320.580.580.651.462.051.85
Other non-operating income-0.20.010.50.380.362.041.982.871.451.45
Pre-tax income3.63.41-1.11-0.44-1.060.681.944.74-0.42-1.66
Income tax11.160.88-0.070.380.440.05-0.47-0.09-1.57
Income from continuing operations2.24-1.99-0.37-1.450.231.89
Net income2.62.5114.4-0.37-1.450.71.895.2-0.33-0.09
EBITDA4.373.76-1.1-0.42-0.98-0.980.312.21-1.58-2.87
EPS, basic0.350.321.83-0.05-0.180.080.210.56-0.04-0.01
EPS, diluted0.340.321.79-0.05-0.180.080.210.55-0.04-0.01
Shares, basic (weighted)7.157.387.577.787.988.238.448.769.049.3
Shares, diluted (weighted)7.47.567.737.787.988.368.488.949.049.3
Dividend per share0.220.220.240.300.150.020.070.110.12

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents7.5410.425.118.119.3202425.230.627.4
Short-term investments0
Receivables1917.7121314.512
Inventory5.585.577.567.825.293.994.372.542.291.44
Other current assets1.591.081.884.652.544.627.042.483.092.52
Total current assets41.850.348.446.541.64959.550.454.852.3
Property, plant and equipment1.680.920.851.271.050.760.650.530.430.54
Lease right-of-use assets2.011.361.160.970.491.65
Intangible assets0.290.170.050.040.030.020.010.050.050.07
Other non-current assets0.190.070.070.120.150.070.110.120.170.18
Total assets48.758.955.359.453.66375.165.969.471.2
Accounts payable4.368.124.4713.55.611.319.25.146.9513.5
Accrued liabilities2.141.531.840.991.021.231.611.961.341.42
Deferred revenue4.70.941.20.740.950.94.11.92.21.5
Short-term debt3.23.13.2
Total current liabilities17.42614.1201317.830.215.718.722.2
Long-term debt0.682.490.880.450
Lease liabilities1.390.820.620.480.121.34
Other non-current liabilities0.540.630.24.783.051.851.611.71
Total liabilities31.137.921.528.924.128.936.119.822.226.6
Paid-in capital12.913.714.715.71718.319.520.822.724.7
Retained earnings16.617.429.927.224.525.226.831.329.827.7
Treasury stock-0.97
Other comprehensive income-11.9-10.2-10.8-12.6-12-9.45-7.33-6.09-5.37-7.99
Shareholders' equity17.72133.830.429.5343946.147.344.6
Total equity17.72133.830.429.5343946.147.344.6
Total liabilities and equity48.758.955.359.453.66375.165.969.471.2
Shares outstanding7.577.87.968.238.478.719.039.469.789.91

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income2.62.5114.4-0.37-1.450.71.895.2-0.33-0.09
Depreciation and amortization0.570.370.510.410.440.380.350.340.290.24
Stock-based compensation0.410.580.690.790.980.980.981.131.581.77
Deferred income tax0.42-0.020.06-0.050.81.150-2.35-0.39-1.74
Change in receivables0.03-0.03-0.040.050.041.08-1.572.47
Change in inventory-0.81-0.57-2.56-0.782.111.26-0.521.56-0.10.67
Change in payables-1.655.21-2.547.23-8.035.738.71-11.61.387.48
Cash from operations52.662.88-3.330.241.92.683.914.212.27
Capital expenditures-0.74-0.21-0.44-0.83-0.23-0.1-0.23-0.23-0.2-0.35
Purchases of investments0-3.530
Cash from investing-0.9-0.5113.6-0.98-0.35-0.170.02-0.34-0.26-0.43
Debt repaid-1.14-0.33-0.74-0.41-0.430
Stock issued0.260.220.25
Share buybacks-0.050-0.17-0.01-0.1-0.87
Dividends paid-1.67-1.72-1.92-2.47-1.260-0.14-0.66-1.02-1.19
Cash from financing-1.41-1.51-1.6-2.250.83-0.951.33-2.41.38-5.04
Exchange rate effect-0.780.14-0.240.43-0.04-0.050.070.030.03
Net change in cash1.920.7814.7-7.011.170.743.981.245.37-3.17
Free cash flow4.272.452.44-4.160.011.812.443.684.021.92
Interest paid0.090.080.070.070.280.190.180.310.210.14
Income taxes paid0.331.140.90.050.020.11-0.230.251.60.45

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $7.71 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin33.1%Gross profit / revenue.
Operating margin-5.3%Operating income / revenue.
EBITDA margin-5.0%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-2.4%Pre-tax income / revenue.
Net margin-1.2%Net income / revenue.
FCF margin-2.5%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-1.9%Cash from operations / revenue.
Return on equity (ROE)-1.5%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-1.0%Net income / average total assets.
Return on invested capital (ROIC)-12.3%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue6.0%Research and development expense / revenue.
SG&A / revenue32.4%Selling, general and administrative expense / revenue.
Stock-based pay / revenue3.2%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.6%Capital expenditures / revenue.
D&A / revenue0.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y6.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y2.6%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-1.0%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-1.8%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-0.6%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y1.5%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-46.2%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-5.4%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y56.2%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-52.2%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-7.7%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y167.6%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y14.3%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y99.6%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y-4.5%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-5.8%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y4.6%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y8.6%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y2.5%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-1.8%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y5.8%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y2.8%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y3.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y3.1%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.40xCurrent assets / current liabilities.
Quick ratio1.76x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio1.20x(Cash + short-term investments) / current liabilities.
Liabilities / assets37.5%Total liabilities / total assets.
Interest coverage-5.29xOperating income / interest expense.
Working capital$28.8MCurrent assets - current liabilities.
Goodwill and intangibles / assets0.1%(Goodwill + intangible assets) / total assets.
Tangible book value$44.2MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.80xRevenue / average total assets.
Fixed asset turnover117xRevenue / average property, plant and equipment.
Inventory turnover20.8xCost of revenue / average inventory.
Days inventory18 days365 x average inventory / cost of revenue.
Receivables turnover5.01xRevenue / average receivables.
Days sales outstanding73 days365 x average receivables / revenue.
Days payables148 days365 x average accounts payable / cost of revenue.
Cash conversion cycle-57 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.07Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$5.95Revenue / diluted weighted shares.
FCF per share-$0.15Free cash flow / diluted weighted shares.
Operating cash flow per share-$0.11Cash from operations / diluted weighted shares.
Book value per share$4.40Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$4.39Tangible book value / shares outstanding.
Cash per share$2.45(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$77.7MShare price x shares outstanding.
Enterprise value$53.1MMarket cap + total debt - cash - short-term investments.
P/S1.37xMarket cap / revenue.
P/B1.76xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.76xMarket cap / tangible book value, when positive.
EV/Sales0.93xEnterprise value / revenue.
FCF yield-1.8%Free cash flow / market cap.
Earnings yield-0.9%Net income / market cap (the inverse of P/E).
What was CSP INC /MA/'s revenue in fiscal 2025?

CSP INC /MA/ reported revenue of $58.7M for fiscal 2025, 6.4% higher than the year before.

Was CSP INC /MA/ profitable in fiscal 2025?

No. It reported a net loss of $91.0K.

How much free cash flow did CSP INC /MA/ generate in fiscal 2025?

Cash from operations of $2.3M minus capital expenditures of $348.0K left free cash flow of $1.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CSP INC /MA/